Literature DB >> 19700237

Oncosuppressor proteins of fragile sites are reduced in cervical cancer.

Enrico Giarnieri1, Nicola Zanesi, Arianna Bottoni, Mauro Alderisio, Ankica Lukic, Aldo Vecchione, Vincenzo Ziparo, Carlo Maria Croce, Rita Mancini.   

Abstract

FHIT and WWOX are tumor suppressor genes that span the common fragile sites FRA3B and FRA16D, respectively. To analyze possible synergisms among these genes in cervical cancer progression, we considered 159 cervical intraepithelial neoplasias, and 58 invasive squamous cell carcinomas of the uterine cervix. All cases were previously selected as high risk HPV. FHIT and WWOX proteins were examined by immunohistochemistry and their expression was inversely correlated with precancerous vs. invasive lesions. Statistics among biological markers indicated an association between FHIT and WWOX. Protein expression of these two genes was also absent or reduced in cancer cell lines. Thus, WWOX may be considered as a novel important genetic marker in cervical cancer and the association between the altered expression of FHIT and WWOX may be a critical event in the progression of this neoplasia. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19700237      PMCID: PMC2987609          DOI: 10.1016/j.canlet.2009.07.017

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  50 in total

1.  Chromosomal fragile sites FRA3B and FRA16D show correlated expression and association with failure of apoptosis in lymphocytes from patients with thyroid cancer.

Authors:  Isabella Sbrana; Franca Veroni; Maria Nieri; Aldamaria Puliti; Roberto Barale
Journal:  Genes Chromosomes Cancer       Date:  2006-05       Impact factor: 5.006

2.  WWOX--the FRA16D cancer gene: expression correlation with breast cancer progression and prognosis.

Authors:  E Płuciennik; R Kusińska; P Potemski; R Kubiak; R Kordek; A K Bednarek
Journal:  Eur J Surg Oncol       Date:  2005-12-15       Impact factor: 4.424

3.  Physical association with WWOX suppresses c-Jun transcriptional activity.

Authors:  Eugenio Gaudio; Alexey Palamarchuk; Tiziana Palumbo; Francesco Trapasso; Yuri Pekarsky; Carlo M Croce; Rami I Aqeilan
Journal:  Cancer Res       Date:  2006-12-15       Impact factor: 12.701

4.  Expression of common chromosomal fragile site genes, WWOX/FRA16D and FHIT/FRA3B is downregulated by exposure to environmental carcinogens, UV, and BPDE but not by IR.

Authors:  Elangovan Thavathiru; John H Ludes-Meyers; Michael C MacLeod; C Marcelo Aldaz
Journal:  Mol Carcinog       Date:  2005-11       Impact factor: 4.784

Review 5.  Roles of FHIT and WWOX fragile genes in cancer.

Authors:  Dimitrios Iliopoulos; Gulnur Guler; Shuang-Yin Han; Teresa Druck; Michelle Ottey; Kelly A McCorkell; Kay Huebner
Journal:  Cancer Lett       Date:  2005-10-12       Impact factor: 8.679

6.  WWOX gene restoration prevents lung cancer growth in vitro and in vivo.

Authors:  Muller Fabbri; Dimitrios Iliopoulos; Francesco Trapasso; Rami I Aqeilan; Amelia Cimmino; Nicola Zanesi; Sai Yendamuri; Shuang-Yin Han; Dino Amadori; Kay Huebner; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-13       Impact factor: 11.205

7.  WWOX mRNA expression profile in epithelial ovarian cancer supports the role of WWOX variant 1 as a tumour suppressor, although the role of variant 4 remains unclear.

Authors:  C Gourley; A J W Paige; K J Taylor; D Scott; N-J Francis; R Rush; C M Aldaz; J F Smyth; H Gabra
Journal:  Int J Oncol       Date:  2005-06       Impact factor: 5.650

8.  Frequent loss of WWOX expression in breast cancer: correlation with estrogen receptor status.

Authors:  María I Nunez; John Ludes-Meyers; Martín C Abba; Hyunsuk Kil; Nancy W Abbey; Robert E Page; Aysegul Sahin; Andrés J P Klein-Szanto; C Marcelo Aldaz
Journal:  Breast Cancer Res Treat       Date:  2005-01       Impact factor: 4.872

9.  WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function.

Authors:  Rami I Aqeilan; Valentina Donati; Alexey Palamarchuk; Francesco Trapasso; Mohamed Kaou; Yuri Pekarsky; Marius Sudol; Carlo M Croce
Journal:  Cancer Res       Date:  2005-08-01       Impact factor: 12.701

10.  Physical and functional interactions between the Wwox tumor suppressor protein and the AP-2gamma transcription factor.

Authors:  Rami I Aqeilan; Alexey Palamarchuk; Ronald J Weigel; Juan J Herrero; Yuri Pekarsky; Carlo M Croce
Journal:  Cancer Res       Date:  2004-11-15       Impact factor: 12.701

View more
  10 in total

1.  Effect of FHIT loss and p53 mutation on HPV-infected lung carcinoma development.

Authors:  Yan Yu; Xiaofei Liu; Yuxuan Yang; Xiaodan Zhao; Jianjun Xue; Weixiao Zhang; Aimin Yang
Journal:  Oncol Lett       Date:  2015-05-15       Impact factor: 2.967

Review 2.  Common fragile site tumor suppressor genes and corresponding mouse models of cancer.

Authors:  Alessandra Drusco; Yuri Pekarsky; Stefan Costinean; Anna Antenucci; Laura Conti; Stefano Volinia; Rami I Aqeilan; Kay Huebner; Nicola Zanesi
Journal:  J Biomed Biotechnol       Date:  2010-12-29

Review 3.  Very large common fragile site genes and their potential role in cancer development.

Authors:  Ge Gao; David I Smith
Journal:  Cell Mol Life Sci       Date:  2014-10-10       Impact factor: 9.261

4.  Molecular biology of gynecological cancer.

Authors:  Kenzo Sonoda
Journal:  Oncol Lett       Date:  2015-11-05       Impact factor: 2.967

5.  Molecular and epigenetic analysis of the fragile histidine triad tumour suppressor gene in equine sarcoids.

Authors:  Maria Strazzullo; Annunziata Corteggio; Gennaro Altamura; Romina Francioso; Franco Roperto; Maurizio D'Esposito; Giuseppe Borzacchiello
Journal:  BMC Vet Res       Date:  2012-03-16       Impact factor: 2.741

Review 6.  Oxidative stress in female cancers.

Authors:  Gloria M Calaf; Ulises Urzua; Lara Termini; Francisco Aguayo
Journal:  Oncotarget       Date:  2018-05-04

7.  FHIT and C-MYC expression in cervical histology and cytology as biomarkers for detecting high-grade intraepithelial neoplasia in human papillomavirus-positive women.

Authors:  Fan Yang; Zifeng Cui; Yuandong Liao; Rui Tian; Weiwen Fan; Zhuang Jin; Zheng Hu; Shuzhong Yao
Journal:  Cancer Biomark       Date:  2020       Impact factor: 4.388

Review 8.  Gynecologic Cancer, Cancer Stem Cells, and Possible Targeted Therapies.

Authors:  Vahideh Keyvani; Espanta Riahi; Meysam Yousefi; Seyed-Alireza Esmaeili; Rana Shafabakhsh; Amin Moradi Hasan-Abad; Maryam Mahjoubin-Tehran; Michael R Hamblin; Samaneh Mollazadeh; Hamed Mirzaei
Journal:  Front Pharmacol       Date:  2022-02-16       Impact factor: 5.810

9.  Nip the HPV encoded evil in the cancer bud: HPV reshapes TRAILs and signaling landscapes.

Authors:  Talha Abdul Halim; Ammad Ahmad Farooqi; Farrukh Zaman
Journal:  Cancer Cell Int       Date:  2013-06-17       Impact factor: 5.722

10.  Relationship of genetic variant distributions of WW domain-containing oxidoreductase gene with uterine cervical cancer.

Authors:  Yu-Hsiang Lin; Yi-Hsuan Hsiao; Wen-Jun Wu; Shun-Fa Yang; Chun-Fang Hsu; Yu-Ting Kang; Po-Hui Wang
Journal:  Int J Med Sci       Date:  2018-06-14       Impact factor: 3.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.